NAD+ Injection Dosage Chart: Why Dosing Is Individual

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, covering longevity compounds, peptide biology, and the genetic variables behind aging-related decisions. Browse the full Peptides & Longevity library.

People search for an "NAD+ injection dosage chart" hoping for a tidy table, and the most useful thing this page can do is explain why that table does not exist in the way the query imagines. Dosing is set by a prescribing provider based on individual factors, indication, and tolerability. This piece reports how dosing is approached, what the literature and labeling context provide, and the upstream genetic variables, without offering any specific dosing direction.

Why there is no universal NAD+ dosage chart

A one-size chart would be misleading. NAD+ dosing is determined by a prescribing provider based on indication, individual factors, and tolerability, and it varies across formats and goals. The clinical literature reports typical adult ranges and FDA-approved labeling exists where applicable, but a fixed public chart cannot account for the individual variables a clinician weighs. That is why specific dosing direction is not provided here.

What NAD+ is

NAD+ is a coenzyme discussed throughout the longevity-protocol space, offered in several formats, with formulation and pricing shown on the relevant product page. It is defined by its cellular role rather than a single indication. Understanding what the compound is helps explain why dosing is individualized rather than standardized: the same molecule is used toward different goals in different people.

How providers approach dosing

Dosing is a clinical process, not a lookup. A prescriber typically starts at the lower end of an established range to assess tolerability, then adjusts, where applicable, based on response and side-effect profile. Titration approaches differ by format and goal, and the schedule is walked through at the start of therapy. The literature provides reference ranges; the actual plan belongs to the clinical conversation.

Body weight and individual factors

Readers often ask whether weight sets the dose. For some compounds and FDA-approved indications, weight-based dosing applies, but many longevity-protocol doses are fixed within a typical range rather than weight-adjusted. Whether weight or other individual factors influence a given dose is a determination a prescribing provider makes, accounting for medical history, goals, tolerability, and concurrent factors, not something a chart can decide.

Starting upstream with PlexusDx

PlexusDx keeps the emphasis on the biology beneath any dosing decision. You can review the Longevity Protocols collection for available formats and begin with the Precision Peptide Genetic Test to understand pathway biology before a dosing conversation. Biology first frames the clinical discussion more usefully than any generic table.

Genetics upstream of the dose decision

Genetics do not set a dose, but they describe the terrain. Variants in FOXO3, SIRT1, and KLOTHO shape the longevity-related pathways NAD+ acts through. These are pathway-level traits; they do not predict response to any compound, and the test is not pharmacogenomic. The Precision Peptide Genetic Test reads them across 14 pathways, 49 peptides, 150+ genetic insights, offering upstream context for a protocol conversation rather than a dosing figure.

Why a chart cannot replace a clinician

The appeal of a dosage chart is understandable: a single table feels like a shortcut past uncertainty. But the reason no universal chart fits is precisely that dosing depends on variables a table cannot hold, indication, format, tolerability, concurrent factors, and individual history. A chart that ignored those would be confidently wrong. The honest alternative is to understand how providers reason about dosing, start low, assess, adjust where appropriate, and to bring your own history into that reasoning. Pathway-level genetic context supports the conversation by describing baseline biology, not by supplying a number. Reading this topic as preparation for a clinical discussion, rather than a substitute for one, is what keeps a dosing decision both safe and genuinely individualized. A well-prepared patient who understands that reasoning tends to have a more productive first visit than one arriving with a chart printed from a search result.

Frequently Asked Questions

Is there a standard NAD+ injection dose?

Typical dosing varies by compound, indication, and individual factors, and clinical literature and FDA labeling provide reference ranges where applicable. Specific dosing direction is determined by your prescribing provider based on your history, goals, tolerability, and concurrent factors. This article does not provide specific dosing instructions.

How is NAD+ dosing usually started?

Initial dosing typically begins at the lower end of an established range to assess tolerability, with provider-directed adjustment where applicable based on response and side-effect profile. Titration approaches differ by format. Your prescribing provider walks through the schedule at the start of therapy rather than following a fixed public chart.

Does body weight change the dose?

Body weight can influence dosing for some compounds, especially weight-based FDA-approved indications. For many longevity-protocol doses, the dose is fixed within a typical range rather than weight-adjusted. Whether weight or other factors apply is a determination your prescribing provider makes, not a blog article.

Can genetic testing set my dose?

No. Genetic testing does not provide compound-specific dose recommendations and is not pharmacogenomic. The Precision Peptide Genetic Test analyzes pathway-level variants in FOXO3, SIRT1, and KLOTHO that shape baseline biology, providing upstream context for protocol decisions while specific dosing stays in the clinical conversation.

Keep reading across the PlexusDx Education Hub. Return to the education library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.